Immunotherapeutics
Immunotherapeutics: the field of research that behaves with treatment of certain diseases involving immune therapy which can also be termed as "Immunotherapeutics".
APR 20, 2021
5:00 PM CEST
APR 20, 2021
5:00 PM CEST
Date: April 20, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers on Oncology - Professor Joan Seoane Prof. Joan Seoane, Group Leader and Director of the Translational Re...
FEB 10, 2021
8:00 AM PST
C.E. CREDITS
FEB 10, 2021
8:00 AM PST
Date: February 10, 2021 Time: 8:00am (PST), 11:00am (EST) Uncovering the interactions between the immune system and cancer cells or pathogens is key for understanding and controlling both ca...
OCT 20, 2020
9:00 AM PDT
C.E. CREDITS
OCT 20, 2020
9:00 AM PDT
DATE: October 20th, 2020 TIME: 08:00am PT, 11:00am ET Tumor-associated macrophages (TAMs) are key cells in the tumor microenvironment (TME) with diverse immune functions that have a major in...
SEP 23, 2020
6:30 AM PDT
SEP 23, 2020
6:30 AM PDT
Single-cell mass cytometry identifies mechanisms of resistance to immunotherapy in AML 6:30–7:00 am PDT Presented By: Shelley Herbrich, PhD Understanding CD19 negative relapse followin...
SEP 17, 2020
12:00 PM PDT
C.E. CREDITS
SEP 17, 2020
12:00 PM PDT
Therapeutic antibody can provide key protection or lifesaving treatment for those who haven't been or can’t be vaccinated, or when vaccines don’t “take". We galvan...
AUG 26, 2020
8:00 AM PDT
C.E. CREDITS
AUG 26, 2020
8:00 AM PDT
DATE: August 26, 2020 TIME: 8:00 am PDT The host immune "recognition" of cancer forms the basis of modern tumor immmunotherapy, a highly targeted treatment option with the demonstr...
JUL 07, 2020
11:00 AM PDT
JUL 07, 2020
11:00 AM PDT
Immune escape mechanisms such as the induction/recruitment of immunosuppressive cells and the increased expression of various immunosuppressive molecules including PD-1/PD-1 ligands are esse...
JUN 18, 2020
9:00 AM PDT
C.E. CREDITS
JUN 18, 2020
9:00 AM PDT
DATE: June 18, 2020 TIME: 9:00am PDT, 12:00pm EDT Despite the success of immunotherapy against several malignancies including melanoma and lung adenocarcinoma, glioblastoma remains the excep...
C.E. CREDITS
B cells have recently come into vogue as important contributors to the anti-tumor immune response in cancer patients. Specifically, B cells and the immune structures in which they reside (te...
MAY 28, 2020
10:00 AM PDT
C.E. CREDITS
MAY 28, 2020
10:00 AM PDT
DATE: May 28, 2020 TIME: 10:00am PT, 1:00pm ET Cardiac allograft rejection is a serious concern in transplant medicine, conferring an increased risk of acute graft failure and adverse patient...
MAY 20, 2020
11:15 AM EDT | APAC MAY 21, 2020 2:15 PM CST
MAY 20, 2020
11:15 AM EDT | APAC MAY 21, 2020 2:15 PM CST
Metastatic prostate cancer (mPC) is a phenotypically diverse disease with poor responses to immune based therapeutics. Development of immunotherapeutic strategies for mPC is hampered by the...
APR 14, 2020
9:00 AM PDT
APR 14, 2020
9:00 AM PDT
DATE: April 14, 2020 TIME: 9:00am PDT, 12:00pm EDT Besides being Gibco Cell Culture Heroes, what do Vivek, Sandra, Daisy, Ameet and Kristine all have in common? They are all stuck at home fo...
MAR 27, 2020
9:00 AM PDT
C.E. CREDITS
MAR 27, 2020
9:00 AM PDT
DATE: March 27, 2020 TIME: 9:00am PDT, 12:00pm EDT Osteoporosis causes a decrease in bone density, along with deterioration of the bone’s microarchitecture at a faster rate than normal...
JAN 30, 2020
9:00 AM PST
C.E. CREDITS
JAN 30, 2020
9:00 AM PST
DATE: January 30, 2020 TIME: 9:00am PST, 12:00pm EST Recent advances in in vitro 3D cellular culture technologies, such as organoids, rapidly developed and established novel, more physiologi...
DEC 17, 2019
9:00 AM PST
C.E. CREDITS
DEC 17, 2019
9:00 AM PST
DATE: December 17, 2019TIME: 9:00am PST, 12:00pm EST Purpose: Liver x receptors (LXRs) are hypothesized to serve as a link between lipid metabolism and inflammation by prom...
NOV 21, 2019
9:00 AM PST
NOV 21, 2019
9:00 AM PST
DATE: November 21, 2019TIME: 9:00am PST, 12:00pm EST Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobu...
OCT 31, 2019
9:00 AM PDT
OCT 31, 2019
9:00 AM PDT
DATE: October 31, 2019TIME: 9:00am PDT, 12:00pm EDT INTRODUCTION: A major limitation for the development of 3D engineered tissues is the absence of viable and perfusable...
OCT 10, 2019
12:00 PM PDT
OCT 10, 2019
12:00 PM PDT
Tumor mutational burden (TMB) is an emerging biomarker that correlates with response to immunotherapeutic agents, such as checkpoint inhibitors. Recent studies indicate that a high mutation l...
OCT 10, 2019
10:30 AM PDT
OCT 10, 2019
10:30 AM PDT
Osteosarcoma (OS) is the most common bone tumor in pediatric and adolescent/young adult patients. Over the past three decades, significant improvements in the survival rates or therapeutic ap...
